Investment
Features
FeesSafety
Academy
More
Pluang+

Compare CSIS WARRANT SERIES I (CSIS-W) vs Diagnos Laboratorium Utama Tbk. (DGNS) Price & Performance

CSIS WARRANT SERIES ITrade
Diagnos Laboratorium Utama Tbk.Trade

Price performance (Past 24H)

Key statistics

CSIS WARRANT SERIES I vs Diagnos Laboratorium Utama Tbk. — how do they compare? CSIS WARRANT SERIES I trades at Rp87 (market cap 4.6B, 5.1K 24h volume), while Diagnos Laboratorium Utama Tbk. trades at Rp222 (market cap 308B, 129.6K 24h volume). The key difference: Diagnos Laboratorium Utama Tbk. is far larger — about 67× CSIS WARRANT SERIES I's market cap, and Diagnos Laboratorium Utama Tbk. is more actively traded (129.6K versus 5.1K). Which is the better fit depends on your goals.

CSIS-WDGNS
Market Cap
4.6B308B
Volume
5.1K129.6K
Lot
511.3K
Turnover
435.6K28.71M
Average Price
85.41221.54
Value
435.6K28.71M
Indicative Equilibrium Price
230
Indicative Equilibrium Volume
110

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

DGNS
View details

About CSIS WARRANT SERIES I

PT Cahayasakti Investindo Sukses Tbk (the Company) was established based on the Deed of Notary Djurnawati Soetarmono, SH, No. 52 dated June 2, 1995. The Company belongs to a group of companies owned by PT Andalan Utama Bintara.

Read more on CSIS-W

About Diagnos Laboratorium Utama Tbk.

PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.

Read more on DGNS